Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, March 11, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Joseph Pantginis Maintained (ATNM) at Strong Buy and Held Target at $50 on, Mar 11th, 2024
Joseph Pantginis of HC Wainwright & Co., Maintained "Actinium Pharmaceuticals, Inc." (ATNM) at Strong Buy and Held Target at $50 on, Mar 11th, 2024.
Joseph has made no other calls on ATNM in the last 4 months.
There is 1 other peer that has a rating on ATNM. Out of the 1 peers that are also analyzing ATNM, 0 agree with Joseph's Rating of Hold.
This is the rating of the analyst that currently disagrees with Joseph
- Yuan Zhi of "B. Riley Securities" Maintained at Strong Buy with Decreased Target to $16 on, Monday, December 11th, 2023
